Acacia Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAcacia Pharma

Acacia Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Barhemsys	Amisulpride	2020-02-26	2031-2038	—
Byfavo	Remimazolam	2020-10-06	2027-2033	Conscious sedation

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

major depressive disorder

,

healthy volunteers/patients

,

gastrointestinal microbiome

,

,

anorexia nervosa

,

psychological stress

,

obsessive-compulsive disorder

,

compulsive behavior

,

compulsive personality disorder

,

chronic kidney failure

,

therapeutic equivalency

,

bipolar disorder

,

intellectual disability

,

postoperative nausea and vomiting

,

,

,

,

psychophysiologic disorders

,

anxiety disorders

,

somatoform disorders

,

,

,

psychotic disorders

,

,

mental disorders

,

treatment-resistant schizophrenia

,

depressive disorder

,

schizophrenia spectrum and other psychotic disorders

,

alzheimer disease

,

tardive dyskinesia

,

,

prodromal symptoms

,

metabolic syndrome

,

hyperprolactinemia

,

,

,

myofascial pain syndromes

,

,

addictive behavior

,

treatment-resistant depressive disorder

,

diabetes mellitus

,

insulin resistance

,

microvascular angina

,

periodontal diseases

Calcium dobesilate

myelodysplastic syndromes

,

myeloid leukemia acute

,

,

biphenotypic leukemia acute

,

neoplasm metastasis

,

precursor cell lymphoblastic leukemia-lymphoma

,

,

,

,

kidney neoplasms

,

follicular lymphoma

,

,

b-cell lymphoma

,

,

hodgkin disease

,

,

pancreatic neoplasms

,

ovarian neoplasms

,

,

,

,

central nervous system neoplasms

,

,

invasive hydatidiform mole

,

,

,

primitive neuroectodermal tumors

,

primitive neuroectodermal tumors peripheral

,

neuroectodermal tumors

,

thyroid neoplasms

,

synovial sarcoma

,

fallopian tube neoplasms

,

epstein-barr virus infections

,

stomach neoplasms

,

,

colorectal neoplasms

,

t-cell lymphoma

,

,

nervous system neoplasms

,

non-small-cell lung carcinoma

,

hepatocellular carcinoma

,

urinary bladder neoplasms

,

liver neoplasms

,

microsatellite instability

,

renal cell carcinoma

,

,

large b-cell lymphoma diffuse

,

triple negative breast neoplasms

,

non-hodgkin lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

,

lymphoid leukemia

,

b-cell chronic lymphocytic leukemia

,

,

acquired immunodeficiency syndrome

,

breast neoplasms

,

,

,

,

drug-related side effects and adverse reactions

,

,

anti-neutrophil cytoplasmic antibody-associated vasculitis

,

,

cytomegalovirus infections

,

communicable diseases

,

hodgkin disease

,

myeloid leukemia acute

,

breast neoplasms

,

mucinous adenocarcinoma

,

ductal carcinoma breast

,

inflammatory breast neoplasms

,

,

chemotherapy-induced febrile neutropenia

,

non-hodgkin lymphoma

,

,

mantle-cell lymphoma

,

promyelocytic leukemia acute

wasting syndrome

,

healthy volunteers/patients

,

diabetes mellitus

,

pharmacokinetics

,

major depressive disorder

,

,

long qt syndrome

,

alzheimer disease

,

,

chronic obstructive pulmonary disease

,

,

respiration disorders

,

,

,

rheumatoid arthritis

,

non-alcoholic fatty liver disease

,

alcoholic fatty liver

,

,

,

healthy volunteers/patients

,

alzheimer disease

,

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use